SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-20-000118
Filing Date
2020-11-12
Accepted
2020-11-12 14:57:35
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20200930.htm   iXBRL 10-Q 1531752
2 EX-31.1 lumo-2020930x10qxex311.htm EX-31.1 9899
3 EX-31.2 lumo-2020930x10qxex312.htm EX-31.2 10170
4 EX-32.1 lumo-2020930x10qxex321.htm EX-32.1 7030
10 nlnk-20200930_g1.jpg GRAPHIC 12762
11 nlnk-20200930_g2.jpg GRAPHIC 79228
  Complete submission text file 0001126234-20-000118.txt   5690980

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20200930.xsd EX-101.SCH 29708
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20200930_cal.xml EX-101.CAL 66938
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20200930_def.xml EX-101.DEF 203503
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20200930_lab.xml EX-101.LAB 455956
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20200930_pre.xml EX-101.PRE 299800
12 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20200930_htm.xml XML 734873
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 201306068
SIC: 2834 Pharmaceutical Preparations